for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Novocure Receives FDA IDE Approval For Its PANOVA 3 Phase 3 Pivotal Clinical Trial In Advanced Pancreatic Cancer

Dec 18 (Reuters) - Novocure Ltd:

* NOVOCURE RECEIVES FDA IDE APPROVAL FOR ITS PANOVA 3 PHASE 3 PIVOTAL CLINICAL TRIAL IN ADVANCED PANCREATIC CANCER

* NOVOCURE LTD - RECEIVED A U.S. FOOD AND DRUG ADMINISTRATION INVESTIGATIONAL DEVICE EXEMPTION APPROVAL TO INITIATE ITS PANOVA 3 CLINICAL TRIAL Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up